Evidence map›Paper›PMID 31066142›Full record

SynthesisEuropean journal of cancer care2019

Availability and effectiveness of decision aids for supporting shared decision making in patients with advanced colorectal and lung cancer: Results from a systematic review.

Inge Spronk, Maartje C Meijers, Marianne J Heins, Anneke L Francke, Glyn Elwyn, Anne van Lindert, Sandra van Dulmen, Liesbeth M van Vliet

Open access · hybridAbstract readSystematic Review
In one paragraph

Synthesis in European journal of cancer care, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 4 pooled it
8.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 4 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 3 countries.

Inge SpronkNivel (Netherlands Institute for Health Services Research), Utrecht, the Netherlands.ORCID https://orcid.org/0000-0001-9571-576X
Maartje C MeijersNivel (Netherlands Institute for Health Services Research), Utrecht, the Netherlands.ORCID https://orcid.org/0000-0001-6492-5035
Marianne J HeinsNivel (Netherlands Institute for Health Services Research), Utrecht, the Netherlands.ORCID https://orcid.org/0000-0002-1794-7407
Anneke L FranckeNivel (Netherlands Institute for Health Services Research), Utrecht, the Netherlands.
Glyn ElwynThe Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth, Massachusetts.ORCID https://orcid.org/0000-0002-0917-6286
Anne van LindertUniversity Medical Center Utrecht, Utrecht, the Netherlands.
Sandra van DulmenNivel (Netherlands Institute for Health Services Research), Utrecht, the Netherlands.ORCID https://orcid.org/0000-0002-1651-7544
Liesbeth M van VlietNivel (Netherlands Institute for Health Services Research), Utrecht, the Netherlands.ORCID https://orcid.org/0000-0001-7965-5998
Leiden University · NLNetherlands Institute for Health Services Research · NLDartmouth Institute for Health Policy and Clinical Practice · USErasmus MC · NLRadboud University Nijmegen · NLUniversity Medical Center Utrecht · NL

Funding

Dutch Cancer Society 10392Dutch Care Institute
6 · The paper itself

Abstract

introductionShared decision making is not always commonplace in advanced colorectal or lung cancer care. Decision aids (DAs) might be helpful. This review aimed (a) to provide an overview of DAs for patients with advanced colorectal or lung cancer and assess their availability; and (b) to assess their effectiveness if possible.

methodsA systematic literature search (PubMed/EMBASE/PsycINFO/CINAHL) and Internet and expert searches were carried out to identify relevant DAs. Data from the DAs included were extracted and the quality of studies, evidence (Grading of Recommendations Assessment, Development and Evaluation) and effectiveness (International Patient Decision Aid Standards) of DAs were determined.

resultsTen of the 12 DAs included (four colorectal cancer, four lung cancer and four generic) are still available. Most (9/12) were applicable throughout the disease pathway and usable for all decisions, or to the decision for supportive care with/without anti-cancer therapy. Seven studies tested effectiveness. Effects on patient outcomes varied, but were generally weakly positive (e.g., DAs improved patient satisfaction) with low evidence. Study quality was fair to good.

conclusionThere is a lack of readily available DAs that have been demonstrated to be effective in advanced colorectal or lung cancer. Rigorous testing of the effects of currently available and future DAs, to improve patient outcomes, is urgently needed.

Indexed as

Decision Making, SharedDecision Support TechniquesColorectal NeoplasmsHumansLung Neoplasmsadvanced colorectal canceradvanced lung cancerdecision aidshared decision making

Identifiers

PMID31066142
PMCPMC9286651
OpenAlexW2944384761

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.